Location History:
- Burnaby, CA (2013)
- Greenwood, AU (2012 - 2015)
Company Filing History:
Years Active: 2012-2015
Title: Keith Stubbs: Innovator in Glycosidase Inhibition
Introduction
Keith Stubbs is a notable inventor based in Greenwood, Australia. He has made significant contributions to the field of glycosidase inhibitors, with a focus on developing compounds that can selectively inhibit glycosidases. His work has implications for treating various diseases and disorders related to O-GlcNAcase.
Latest Patents
Keith Stubbs holds a total of 3 patents. His latest patents include innovative compounds designed for selectively inhibiting glycosidases. These inventions provide compounds of formula (I) for this purpose, along with prodrugs and pharmaceutical compositions that incorporate these compounds. The methods outlined in his patents aim to address diseases and disorders associated with the deficiency or overexpression of O-GlcNAcase, as well as the accumulation or deficiency of O-GlcNAc.
Career Highlights
Keith Stubbs is affiliated with Simon Fraser University, where he continues to advance his research in glycosidase inhibitors. His academic background and ongoing research contribute to the understanding and treatment of related health issues.
Collaborations
Throughout his career, Keith has collaborated with esteemed colleagues such as David Jaro Vocadlo and Ernest John McEachern. These partnerships have enhanced the scope and impact of his research.
Conclusion
Keith Stubbs is a prominent figure in the field of glycosidase inhibition, with a focus on developing innovative solutions for health-related challenges. His contributions through patents and collaborations continue to influence the scientific community.